| Issue Date | Title | Author(s) |
| 2021 | Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies. | Law, AMK; Rodriguez de la Fuente, L; Grundy, TJ; Fang, G; Valdes-Mora, F; Gallego-Ortega, D |
| 2016-12-08 | MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. | Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2017-04-18 | Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer. | Valdés-Mora, F; Locke, WJ; Bandrés, E; Gallego-Ortega, D; Cejas, P; García-Cabezas, MA; Colino-Sanguino, Y; Feliú, J; Del Pulgar, TG; Lacal, JC |
| 2021-06-03 | Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study | Bark, JM; Kulasinghe, A; Hartel, G; Leo, P; Warkiani, ME; Jeffree, RL; Chua, B; Day, BW; Punyadeera, C |
| 2021-08-01 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Xiao, L; Somers, K; Murray, J; Pandher, R; Karsa, M; Ronca, E; Bongers, A; Terry, R; Ehteda, A; Gamble, LD; Issaeva, N; Leonova, KI; O'Connor, A; Mayoh, C; Venkat, P; Quek, H; Brand, J; Kusuma, FK; Pettitt, JA; Mosmann, E; Kearns, A; Eden, G; Alfred, S; Allan, S; Zhai, L; Kamili, A; Gifford, AJ; Carter, DR; Henderson, MJ; Fletcher, JI; Marshall, G; Johnstone, RW; Cesare, AJ; Ziegler, DS; Gudkov, AV; Gurova, KV; Norris, MD; Haber, M |
| 2016-09-13 | Short term ex-vivo expansion of circulating head and neck tumour cells. | Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C |
| 2016-07-15 | Single-cell profiling approaches to probing tumor heterogeneity. | Khoo, BL; Chaudhuri, PK; Ramalingam, N; Tan, DSW; Lim, CT; Warkiani, ME |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
| 2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
